Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers

Human Psychopharmacology: Clinical and Experimental, EarlyView.

Source: Human Psychopharmacology: Clinical and Experimental - October 25, 2018 Category: Psychiatry Authors: Michael S. Zastrozhin, Aleksandr S. Sorokin, Tatyana V. Agibalova, Elena A. Grishina, Anastasiya Р. Antonenko, Ilya N. Rozochkin, Denis V. Duzhev, Valentine Y. Skryabin, Tatyana E. Galaktionova, Ilya V. Barna, Anna V. Orlova, Albert D. Aguzaro Source Type: research